Mefenamic Acid Tillomed Laboratories

Mefenamic acid, the active ingredient in Mefenamic Acid Tillomed Laboratories, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral formulation for systemic use. It is used to relieve mild to moderate pain and inflammation, particularly in conditions such as dysmenorrhea, musculoskeletal pain, and other inflammatory disorders. The product conforms to EU market standards and is available by prescription.

GNH USA supplies Mefenamic Acid Tillomed Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mefenamic acid is an NSAID that reduces inflammation and pain by inhibiting prostaglandin synthesis.

- Dysmenorrhea: provides relief from menstrual cramps and associated pain. - Musculoskeletal pain: alleviates pain from strains, sprains, and low‑back discomfort. - Inflammatory conditions: reduces swelling and discomfort in conditions such as osteoarthritis or soft‑tissue inflammation.

Mefenamic acid may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or dyspepsia. - Headache or dizziness. - Diarrhea.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment or reduced kidney function. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatic dysfunction. - Anaphylactic or severe allergic reactions. - Blood dyscrasias including agranulocytosis.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Renal function: assess baseline kidney status and monitor during treatment. - Gastrointestinal risk: consider co‑administration with food or antacids to lessen irritation. - Cardiovascular health: avoid in patients with uncontrolled hypertension or heart failure. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Drug interactions: review concomitant NSAIDs, anticoagulants, and antihypertensives. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Mefenamic acid can interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened hemorrhage risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: may reduce renal function. - Lithium: NSAIDs can raise lithium serum concentrations. - Methotrexate: reduced clearance may lead to toxicity.